Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.38%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +22.68%
#5 Tutorial Tutorial +22.05%
#6 Codatta Codatta +16.69%
#7 Humanity Humanity +16.02%
#8 Ribbita by Virtuals Ribbita by Virtuals +14.73%
#9 Enso Enso +14.41%
#10 Cysic Cysic +12.50%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
주식 순위 #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
주가
$0.6
마지막 동기화: 2024-08-14
시가총액
$2.09M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
SG
거래 ASLAN Pharmaceuticals Limited (ASLN)

카테고리

Healthcare
ASLAN Pharmaceuticals Limited (ASLN)의 발행 주식 수
March 2024 기준 발행 주식 수: 4.67M
ASLAN Pharmaceuticals Limited의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 4.67M입니다. December 2022 말 기준 회사는 3.49M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
ASLAN Pharmaceuticals Limited (ASLN)의 발행 주식 수 기록 (2014 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 4.67M 13.50%
2023 4.11M 17.93%
2022 3.49M 7.07%
2021 3.26M 69.43%
2020 1.92M 18.37%
2019 1.62M 8.45%
2018 1.50M 20.35%
2017 1.24M -4.34%
2016 1.30M 136.41%
2015 550.22K 761.10%
2014 63.90K 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,339.61%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,232.28%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE